MET - Overview: Methemoglobin and Sulfhemoglobin, Blood

Diagnosing methemoglobinemia and sulfhemoglobinemia Identifying cyanosis due to other causes, such as congenital heart disease

HGU - Overview: Mercury, 24 Hour, Urine

Detecting mercury toxicity using 24-hour urine specimens

MPA - Overview: Mycophenolic Acid, Serum

Monitoring therapy to ensure adequate blood levels and avoid over-immunosuppression

SIIRO - Overview: Sirolimus, Whole Blood

Monitoring whole blood sirolimus concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...

MNCU - Overview: Manganese/Creatinine Ratio, Urine

Measurement of manganese as a part of a profile Monitoring manganese exposure Nutritional monitoring Clinical trials

TAKRO - Overview: Tacrolimus, Blood

Monitoring whole blood tacrolimus concentration during therapy, particularly in individuals coadministered cytochrome P450 (CYP) 3A4 substrates, inhibitors, or inducers Adjusting dose to optimize immunosuppression while minimizing...

POSA - Overview: Posaconazole, Serum

Monitoring posaconazole therapy

HPP - Overview: Pancreatic Polypeptide, Plasma

Detecting pancreatic endocrine tumors Assessing vagal nerve function after meal or sham feeding

FRT4 - Overview: T4 (Thyroxine), Free, Serum

Evaluating suspected thyroid function disorders using free thyroxine measured together with thyroid-stimulating hormone

THEO - Overview: Theophylline, Serum

Assessing and adjusting theophylline dosage for optimal therapeutic level Assessing theophylline toxicity